Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is there something you wanted to say?
Maybe you expect new products to to just occur. Without any work and costs.
Still I would very much like to know what is Sampsa thinking he is doing in behalf of other present owners.
Par market share for Focalin is somewhere around 10%.
Imagine if MNK share for Seroquel will soon be same and 25% of that will be forwarded to IPCI. It would make something like $25M a year.
Your firs number 347.41 is mostly from august. Not september.
Seems to be +11% now.
After seeing the last sales numbers it will be interesting to see two thing:
- How is it with Q3 revenue and EPS.
- Even more interesting is to see what do they expect it to be in the future.
If sales continues growing, this will be just fine in no time even without any new products.
Nice growth. Let's hope IPCI can keep on supplying it enough.
Even though for share price it would be good if they annonced sales are even better than they expected ;)
Is there any news in latest Seroquel sales?